ADC Therapeutics Announces Zynlonta Updates in Japan
ADC Therapeutics announced updates concerning Zynlonta in Japan; the details were not provided.
Related stories
Ibiden Shares Fall 15% in Tokyo
M impact | EQUITY | Oct 30, 2026, 12:34 AM UTC
KOSPI Nears Risk of Falling Below 5,700
The report says the KOSPI is at risk of slipping below 5,700, citing Alphabet’s 13% plunge.
M impact | EQUITY | Oct 30, 2026, 12:34 AM UTC
GS Engineering & Construction Q3 Operating Profit Falls 35.65%
The company's Q3 operating profit fell 35.65% year on year.
M impact | EQUITY | Oct 30, 2026, 12:33 AM UTC
HANMI Semiconductor Q3 Operating Profit Rises 33.9% Year on Year
M impact | EQUITY | Oct 30, 2026, 12:30 AM UTC
CS Wind Discloses KRW 308.56 Billion Wind Turbine Structure Supply Contract
CS Wind disclosed a KRW 308.56 billion wind turbine structure supply contract with Vattenfall.
M impact | EQUITY | Oct 30, 2026, 12:30 AM UTC
Global market picture: S&P 500 -0.7%, Nasdaq 100 -1.7%; EUR/USD +0.09%, WTI +0.7%
Global market picture. US index futures: S and P futures is down 0.7 percent, Nasdaq futures is down 1.7 percent, Dow futures is up 0.08 percent and Russell futures is down 0.01 pe
M impact | EQUITY | Oct 30, 2026, 12:30 AM UTC